Profiles of Leading Women Scientists on AcademiaNet.
Search among the members of the Leopoldina for experts in specific fields or research topics.
Image: Markus Scholz | Leopoldina
Year of election: | 2021 |
Section: | Radiology |
City: | Boston, MA |
Country: | USA |
Research Priorities: Medical physics, intensity-modulated radiation therapy (IMRT), proton therapy, optimisation methods
Thomas Bortfeld is a German-American physicist who has made substantial contributions to developments in radiation therapy. When it comes to treating tumours, the main challenge relates to delivering a therapeutically effective dose to the tumour without exceeding the threshold that can be tolerated by the surrounding normal tissue. Together with his team, Thomas Bortfeld is developing models and algorithms for calculating the best-possible treatment strategy in each case as well as technologies for its clinical implementation. The intensity-modulated radiation therapy (IMRT) method – a development to which he has substantially contributed – has now been used in the treatment of 30 million patients worldwide.
From a mathematical perspective, radiation therapy is an inverse problem in which the intensity and direction of the radiation fields used must be inferred from the desired dose in the target volume of the tumour. This problem is mathematically linked to the reconstruction of computed tomography (CT) images from measured X-ray projections. Unlike image reconstruction, there is no exact solution to be found when planning treatment; rather, the best possible compromise, taking into account objectives and side conditions, must be sought. This is known as multi-objective optimisation. Thomas Bortfeld and his team focus on formulating and solving this optimisation problem during the treatment planning process.
Another aspect is delivering intensity-modulated radiation fields with multileaf collimators that match the treatment volume irradiated to the object to be treated and to enable geometrically differentiated dosing. This work has led to inverse intensity-modulated radiation therapy (IMRT) planning in which the intensity of the radiation dose within the radiation field can be changed and adapted to the radiosensitivity of the tissue with pinpoint accuracy. This enables radiotherapy to be targeted very precisely at the tumour while protecting the healthy surrounding structures from radiation. In turn, this means that a higher radiation dose can be used, thus improving the chances of patient recovery. IMRT is now considered the state of the art in radiation therapy worldwide.
Current research priorities include developing optimal stopping methods for improving tailored therapies, systematically determining the clinical target volume (CTV), and developing methods for cutting proton therapy costs with a view to making this type of treatment accessible to more patients.